Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 cases. - Wikidata - wikimedia - TriplyDB

Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 cases.

Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 cases.

http://www.wikidata.org/entity/Q48762572

about

A heritable form of SMARCE1-related meningiomas with important implications for follow-up and family screening.A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review Neurofibromatosis Type 2 Presenting with Oculomotor Ophthalmoplegia and Distal Myopathy.Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors Neurofibromatosis type 2.Yes-associated protein 1 is activated and functions as an oncogene in meningiomas.Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2.Long-term follow-up of 287 meningiomas in neurofibromatosis type 2 patients: clinical, radiological, and molecular features.Multiple primary cranio-spinal tumours in a 13-year-old female with neurofibromatosis type 2 management strategy.Multiple meningiomas: differential involvement of the NF2 gene in children and adults.Pediatric meningioma: current approaches and future direction.Meningiomas and neurofibromatosis.Pediatric meningiomas: a single-center experience with 15 consecutive cases and review of the literature.Morbidity in survivors of child and adolescent meningioma Meningiomas in children: A study of 18 cases.Group I Paks as therapeutic targets in NF2-deficient meningioma.Meningioma pathology, genetics, and biology.Meningioma: a clinicopathological evaluation Insights into meningioangiomatosis with and without meningioma: a clinicopathologic and genetic series of 24 cases with review of the literature.Evaluation of NF2 gene deletion in sporadic schwannomas, meningiomas, and ependymomas by chromogenic in situ hybridization Meningiomas in children.Children's Cancer and Leukaemia Group (CCLG): guidelines for the management of intracranial meningioma in children and young people.Pediatric meningiomas an aggressive subset: a clinicopathological and immunohistochemical study.Childhood and adolescent meningiomas: a report of 38 cases and review of literature.Neurofibromatosis 2 [Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II].Neurooncology of familial cancer syndromes.Gone FISHing: clinical lessons learned in brain tumor molecular diagnostics over the last decade.16 month-old female with intraventricular mass.Intracranial clear cell meningioma in two children with blood relations: two case reports and literature review.Pediatric microcystic meningioma: a clinical, histological, and radiographic case-based review.Association of Genetic Predisposition With Solitary Schwannoma or Meningioma in Children and Young Adults.Brain invasion in Meningiomas - Clinical considerations and impact of neuropathological evaluation: A systematic Review.Descriptive epidemiology of pediatric intracranial neoplasms in Egypt.Membrane localization of the U2 domain of Protein 4.1B is necessary and sufficient for meningioma growth suppression.Loss of tumor suppressor in lung cancer-1 (TSLC1) expression in meningioma correlates with increased malignancy grade and reduced patient survival.Glutamate metabolism in HIV-1 infected macrophages: Role of HIV-1 Vpr.Immunolocalization of protein 4.1B/DAL-1 during neoplastic transformation of mouse and human intestinal epithelium.Surgery versus stereotactic radiosurgery for the treatment of multiple meningiomas in neurofibromatosis type 2: illustrative case and systematic review.

P2860

Q26775218-FAE3672E-D608-4EC4-BC24-68A5AB744729 Q30252766-B4B09F4B-2D9A-4A9E-AE89-D823C3B3EE00 Q30274790-DF7D56A1-3940-4095-AD40-BA12321F3D4A Q30356126-714E4D5D-838D-44DD-907A-FB165A5CE36F Q30372453-91E2B807-974D-4D53-9CA8-1E5ACB379CCE Q30391370-427B437E-C843-4379-B5A5-CAA470526C90 Q30391375-0D0FC1C8-EF32-4971-B99F-033BF8374B14 Q30394387-D4F9F72A-1B34-413B-B755-EC3D62546D1A Q30406342-466EF777-1B3B-43DF-A329-F2133BB6D01D Q30451619-BD51978D-420F-4F0A-9271-4BD2940F861D Q30477143-7011B362-5757-4474-AE6A-882D2F3C5752 Q30495317-BB73AA16-8D06-4E14-A21F-03DE4217EB73 Q33785024-707F3F9C-12F1-4899-A2D3-7BC20F347627 Q34131583-D2D11980-66D4-4381-ABBD-C190665C8EED Q34293658-B9C3C043-7288-48AC-9FE6-C1D1A98C5492 Q34402586-3746FEE9-A93D-4C3D-9100-A74ABEE8495F Q35183928-4143A32B-588A-4E72-982E-E21098D63AEE Q35273319-DB45C45F-8FB4-4C13-AADD-07A3BAAD9889 Q35751662-E3637101-90AD-49DA-AF85-9A39526D4B9E Q35956175-D2D55DAC-BB04-4D46-A4A2-3284C52FFB16 Q36075465-CF672D14-7AAC-4CA8-B921-7A60FD908C59 Q36168966-18EB3E2E-8471-44DC-8DD3-93AD3EF4225E Q37039481-98720A9D-DE58-414D-9D67-A77D5A7BE674 Q37068833-D14B41FC-6231-4705-9FC9-7C5F9BC739B6 Q37093659-BDAC9F08-95BA-4146-A4EC-4F95C25AE51E Q37399923-19BB9A10-4599-4275-B574-36C2DC6D37ED Q37571402-79585063-50C1-45FE-A8D9-D84E0FC5FE56 Q37643115-2B6F052A-0636-4959-87C0-C2BCDEBF5999 Q37815544-0CF4EEE2-0AE4-4BCD-875B-7762B1D0AF76 Q37865065-F08F82E8-8D6B-4A49-B48C-927D49D98CBB Q38027778-DFEA5747-74CF-4A68-BC45-7FF44FCC95DB Q38068323-590E8982-8E32-4BD4-8FE7-3258761D1022 Q38651537-F14F3BA7-EFC6-4240-AA5F-E7196B1232D4 Q38728877-E0926993-1C06-4184-A23C-41A0990D1F2F Q38987195-332BAD44-4F38-48D9-8571-339B20F8E95F Q40462570-E334C660-56B9-43C1-978C-2A14FB66E8DF Q40494023-7B63B688-5A36-4D9A-8993-F46655A9A10B Q40651480-F5684AAA-449F-4B60-8235-907669616152 Q42166023-C08E4DBF-8C55-487A-81AD-0D01F928F983 Q46080652-7C4F1895-6CF7-4322-93B9-B3D19C868A25

P2860

Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 cases.

http://www.wikidata.org/entity/Q48762572

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Aggressive phenotypic and geno ...... opathologic study of 53 cases.

@en

Aggressive phenotypic and geno ...... opathologic study of 53 cases.

@nl

type

label

Aggressive phenotypic and geno ...... opathologic study of 53 cases.

@en

Aggressive phenotypic and geno ...... opathologic study of 53 cases.

@nl

prefLabel

Aggressive phenotypic and geno ...... opathologic study of 53 cases.

@en

Aggressive phenotypic and geno ...... opathologic study of 53 cases.

@nl

P1433

Q48762572-FDBBB087-9B04-40BC-AF28-D850A1AE48BD

P1476

Q48762572-47761405-E456-4EA3-AB4F-56E0D1C5DE6E

P2093

Q48762572-01EFD4DB-63AC-41C6-83DB-D96CD53DC056

Q48762572-13A9B8F8-3692-4546-9B52-FE28B98322AA

Q48762572-250FD1B2-A257-4877-AEC7-A13F7C8E3DB3

Q48762572-4E89751E-05E6-42EC-9FA9-BCAF38EE2101

Q48762572-57DF3CEA-EB92-4572-B722-F1FD5F5EE956

Q48762572-70FDA202-9F4A-4883-AE36-D0DAF7739EDB

Q48762572-9F914016-2582-482F-A737-F53278B6D6D0

Q48762572-A275F1F7-ACFC-4286-BC6E-ABCB9F8F54D7

Q48762572-D3D8B8E2-0F3A-4FD2-A665-2A2BE29C632E

Q48762572-DDC55A5A-C90D-417A-BEFF-C8BECB08A85B

P2860

Q48762572-08A558CF-10C3-4461-BB31-FC4EC23ECD6D

Q48762572-1733D0F7-758B-444E-B05C-B76077D864DD

Q48762572-1D86BDF7-BB8D-46C8-A718-DA71C68902D9

Q48762572-21F3E99B-ACA8-480E-9C60-88D772E49D7D

Q48762572-280F50A1-7DD6-42BE-B7AF-EB80DD7DBA1F

Q48762572-312A9D5B-2755-4D16-9EC8-7B8A67E6E558

Q48762572-3C636FBA-FE71-4F97-9E36-5E3901AAF13E

Q48762572-49AC95C1-BF97-4841-9B1A-F32E4981BB48

Q48762572-4A7DF5EB-AF5B-49C3-AF2C-0C856BCAE164

Q48762572-4B63FFDD-C590-4486-8EB5-2597D6EC22F6

P304

Q48762572-287CEA6D-FCB5-4182-85CE-F91BCC05B9AB

P31

Q48762572-18B982F7-CA47-4C08-B407-1EF0D07E5A62

P356

Q48762572-D78847AB-94C6-4863-840A-4979BA200975

P433

Q48762572-BE32ABE9-BA6D-4A04-A4C5-A41D7328BD4C

P478

Q48762572-930E2A68-380B-43BA-92FE-0382594706A6

P577

Q48762572-A41DF365-2F76-44CA-A56D-8A91E803A41C

P5875

Q48762572-DC42627C-6071-48A3-945C-BF41A968FB2A

P698

Q48762572-6316EDAC-8290-4863-A3B8-274A90D1524C

P356

P1433

Journal of Neuropathology & Experimental Neurology

P1476

Aggressive phenotypic and geno ...... opathologic study of 53 cases.

@en

P2093

Banerjee R

http://www.w3.org/2001/XMLSchema#string

Bowers DC

http://www.w3.org/2001/XMLSchema#string

Giannini C

http://www.w3.org/2001/XMLSchema#string

Gutmann DH

http://www.w3.org/2001/XMLSchema#string

Lytle RA

http://www.w3.org/2001/XMLSchema#string

Margraf L

http://www.w3.org/2001/XMLSchema#string

Newsham IF

http://www.w3.org/2001/XMLSchema#string

Perry A

http://www.w3.org/2001/XMLSchema#string

Raghavan R

http://www.w3.org/2001/XMLSchema#string

Scheithauer BW

http://www.w3.org/2001/XMLSchema#string

P2860

Mutation and cancer: statistical study of retinoblastoma

Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas

Loss of chromosomes 22 and 14 in the malignant progression of meningiomas. A comparative study of fluorescence in situ hybridization (FISH) and standard cytogenetic analysis.

Paediatric presentation of type 2 neurofibromatosis.

Meningiomas of the central nervous system occurring below the age of 17: report of 24 cases not associated with neurofibromatosis and review of literature.

Chordoid meningioma: a clinicopathologic study of 42 cases.

The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.

Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression.

Neuropathology and molecular genetics of neurofibromatosis 2 and related tumors.

Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma.

P304

994-1003

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNEN/60.10.994

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P577

2001-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232204294

http://www.w3.org/2001/XMLSchema#string

P698

11589430

http://www.w3.org/2001/XMLSchema#string